slotkoers
Taipei Exchange
00:00:00 21-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
24,15
TWD
|
-1,02%
|
|
+1,90%
|
-9,21%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
2.840
|
2.634
|
3.152
|
2.675
|
3.506
|
2.909
|
Bedrijfswaarde
1 |
2.368
|
2.177
|
2.733
|
2.287
|
3.011
|
2.371
|
K/w-verhouding
|
49,1
x
|
78,3
x
|
81,4
x
|
8.267
x
|
-285
x
|
99,2
x
|
Dividendrendement
|
1,06%
|
1,86%
|
1,38%
|
1,41%
|
0,54%
|
0,56%
|
Marktkapitalisatie/omzet
|
6,23
x
|
5,66
x
|
6,67
x
|
6,16
x
|
7,99
x
|
5,5
x
|
Bedrijfswaarde/omzet
|
5,2
x
|
4,67
x
|
5,78
x
|
5,27
x
|
6,86
x
|
4,49
x
|
Bedrijfswaarde/EBITDA
|
37,5
x
|
30,5
x
|
37,8
x
|
70,7
x
|
151
x
|
38,9
x
|
Bedrijfswaarde/FCF
|
-199
x
|
195
x
|
81,4
x
|
-97
x
|
-816
x
|
40,3
x
|
FCF Yield
|
-0,5%
|
0,51%
|
1,23%
|
-1,03%
|
-0,12%
|
2,48%
|
Price to Book
|
1,82
x
|
1,86
x
|
2,21
x
|
1,94
x
|
2,52
x
|
1,98
x
|
Aantal aandelen (in duizenden)
|
109.436
|
109.404
|
107.876
|
107.876
|
107.876
|
109.376
|
Referentieprijs
2 |
25,95
|
24,08
|
29,22
|
24,80
|
32,50
|
26,60
|
Datum van publicatie
|
28/03/19
|
30/03/20
|
26/03/21
|
29/03/22
|
25/03/23
|
28/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
455,8
|
465,8
|
472,7
|
434,3
|
438,8
|
528,5
|
EBITDA
1 |
63,08
|
71,49
|
72,32
|
32,33
|
19,94
|
60,9
|
Bedrijfsresultaat (EBIT)
1 |
31,59
|
39,48
|
39,5
|
-1,166
|
-13,89
|
27,01
|
Operationele Marge
|
6,93%
|
8,48%
|
8,36%
|
-0,27%
|
-3,17%
|
5,11%
|
Resultaat voor belastingen (EBT)
1 |
63,94
|
40,67
|
40,76
|
3,568
|
-9,001
|
30,82
|
Nettowinst (verlies)
1 |
57,85
|
34,06
|
38,73
|
0,372
|
-12,32
|
29,33
|
Nettomarge
|
12,69%
|
7,31%
|
8,19%
|
0,09%
|
-2,81%
|
5,55%
|
WPA
2 |
0,5286
|
0,3076
|
0,3590
|
0,003000
|
-0,1142
|
0,2682
|
Free Cash Flow
1 |
-11,88
|
11,18
|
33,59
|
-23,57
|
-3,688
|
58,76
|
FCF-marge
|
-2,61%
|
2,4%
|
7,11%
|
-5,43%
|
-0,84%
|
11,12%
|
Kasstroomconversie (ebitda)
|
-
|
15,64%
|
46,44%
|
-
|
-
|
96,47%
|
Kasstroomconversie (nettowinst)
|
-
|
32,84%
|
86,72%
|
-
|
-
|
200,3%
|
Dividend per aandeel
2 |
0,2746
|
0,4469
|
0,4020
|
0,3500
|
0,1750
|
0,1500
|
Datum van publicatie
|
28/03/19
|
30/03/20
|
26/03/21
|
29/03/22
|
25/03/23
|
28/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
472
|
457
|
419
|
389
|
495
|
539
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-11,9
|
11,2
|
33,6
|
-23,6
|
-3,69
|
58,8
|
ROE (netto-inkomsten/eigen vermogen)
|
3,66%
|
2,29%
|
2,73%
|
0,03%
|
-0,88%
|
2,04%
|
ROA (netto-inkomsten/totale activa)
|
1,05%
|
1,49%
|
1,57%
|
-0,05%
|
-0,56%
|
1,07%
|
Totale activa
1 |
5.535
|
2.283
|
2.466
|
-788,1
|
2.186
|
2.750
|
Nettoactief per aandeel
2 |
14,30
|
12,90
|
13,20
|
12,80
|
12,90
|
13,40
|
Cashflow per aandeel
2 |
2,010
|
1,840
|
2,070
|
1,840
|
1,780
|
1,650
|
Capex
1 |
35,3
|
25,8
|
27
|
18
|
23,5
|
28
|
Capex/omzet
|
7,74%
|
5,53%
|
5,71%
|
4,14%
|
5,37%
|
5,29%
|
Datum van publicatie
|
28/03/19
|
30/03/20
|
26/03/21
|
29/03/22
|
25/03/23
|
28/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -9,21% | 82,7 mln. | | +37,78% | 705 mld. | | +32,82% | 583 mld. | | -3,51% | 364 mld. | | +19,94% | 332 mld. | | +5,14% | 291 mld. | | +16,64% | 238 mld. | | -4,13% | 210 mld. | | +10,63% | 209 mld. | | +9,32% | 169 mld. |
Farmaceutische producten - Andere
|